We are proud to share the next chapter of our partnership with Novoskin, a biotech company specializing in innovative treatments for burns, trophic ulcers, and chronic wounds. Our latest project focused on expanding Novoskin's artificial skin solution in the Russian healthcare sector.
Engaging Key Healthcare Facilities
We organized and conducted six targeted meetings across diverse healthcare facilities, including:
Our team collaborated closely with Novoskin’s CEO, facilitating in-depth discussions with representatives from hospitals. During these meetings, we focused on understanding the current landscape and needs of the medical community.
The feedback allowed us to identify specific gaps in the market and match Novoskin’s offerings to the needs of medical professionals.
Establishing Key Agreements
As a direct result of these engagements, we achieved the following milestones:
A Promising Future for Novoskin
Through these targeted efforts, Novoskin has taken critical steps toward establishing a strong foothold in the Russian market. The ongoing product trials and initial purchase order represent significant steps toward broader market penetration.
At Income, we remain dedicated to supporting Novoskin’s growth and look forward to witnessing their continued success in the healthcare sector.
Income. Your architect for constructing a thriving business.
Engaging Key Healthcare Facilities
We organized and conducted six targeted meetings across diverse healthcare facilities, including:
- Sklifosovsky Institute for Emergency Medicine (Burn Unit)
- A.V. Vishnevsky National Medical Research Center of Surgery
- MEDSI Clinic
Our team collaborated closely with Novoskin’s CEO, facilitating in-depth discussions with representatives from hospitals. During these meetings, we focused on understanding the current landscape and needs of the medical community.
The feedback allowed us to identify specific gaps in the market and match Novoskin’s offerings to the needs of medical professionals.
Establishing Key Agreements
As a direct result of these engagements, we achieved the following milestones:
- Agreements for product trials were secured with two hospitals.
- One hospital committed to purchasing 200 units of Novoskin’s product.
A Promising Future for Novoskin
Through these targeted efforts, Novoskin has taken critical steps toward establishing a strong foothold in the Russian market. The ongoing product trials and initial purchase order represent significant steps toward broader market penetration.
At Income, we remain dedicated to supporting Novoskin’s growth and look forward to witnessing their continued success in the healthcare sector.
Income. Your architect for constructing a thriving business.